Header cover image

Swiss (SMI) Drug Retail Industry Analysis

UpdatedMay 05, 2024
DataAggregated Company Financials
Companies1
  • 7D-4.2%
  • 3M-2.8%
  • 1Y126.1%
  • YTDn/a

The Drug Retail industry has stayed flat over the last week. The past year has been better, since the industry has gained 132% in that time. Earnings are forecast to grow by 67% annually.

Industry Valuation and Performance

Has the Swiss Drug Retail Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 05 May 2024CHF1.0bCHF969.5m-CHF117,565,000.00n/a-8.7x1.1x
Tue, 02 Apr 2024CHF1.1bCHF969.5m-CHF117,565,000.00n/a-9.1x1.1x
Thu, 29 Feb 2024CHF978.4mCHF1.6b-CHF145,782,000.00n/a-6.7x0.6x
Sat, 27 Jan 2024CHF910.8mCHF1.6b-CHF145,782,000.00n/a-6.2x0.6x
Mon, 25 Dec 2023CHF868.5mCHF1.6b-CHF145,782,000.00n/a-6x0.6x
Wed, 22 Nov 2023CHF593.3mCHF1.6b-CHF145,782,000.00n/a-4.1x0.4x
Fri, 20 Oct 2023CHF461.0mCHF1.6b-CHF145,782,000.00n/a-3.2x0.3x
Sun, 17 Sep 2023CHF644.4mCHF1.6b-CHF145,782,000.00n/a-4.4x0.4x
Tue, 15 Aug 2023CHF599.8mCHF1.6b-CHF171,115,000.00n/a-3.5x0.4x
Thu, 13 Jul 2023CHF554.7mCHF1.6b-CHF171,115,000.00n/a-3.2x0.3x
Sat, 10 Jun 2023CHF351.8mCHF1.6b-CHF171,115,000.00n/a-2.1x0.2x
Mon, 08 May 2023CHF422.1mCHF1.6b-CHF171,115,000.00n/a-2.5x0.3x
Wed, 05 Apr 2023CHF506.7mCHF1.7b-CHF234,788,000.00n/a-2.2x0.3x
Fri, 03 Mar 2023CHF599.6mCHF1.7b-CHF234,788,000.00n/a-2.6x0.4x
Sun, 29 Jan 2023CHF425.2mCHF1.7b-CHF234,788,000.00n/a-1.8x0.2x
Tue, 27 Dec 2022CHF332.6mCHF1.7b-CHF234,788,000.00n/a-1.4x0.2x
Thu, 24 Nov 2022CHF328.0mCHF1.7b-CHF234,788,000.00n/a-1.4x0.2x
Sat, 22 Oct 2022CHF324.2mCHF1.7b-CHF234,788,000.00n/a-1.4x0.2x
Mon, 19 Sep 2022CHF422.5mCHF1.7b-CHF234,788,000.00n/a-1.8x0.2x
Wed, 17 Aug 2022CHF610.0mCHF1.7b-CHF225,735,000.00n/a-2.7x0.4x
Fri, 15 Jul 2022CHF678.2mCHF1.7b-CHF225,735,000.00n/a-3x0.4x
Sun, 12 Jun 2022CHF978.1mCHF1.7b-CHF225,735,000.00n/a-4.3x0.6x
Tue, 10 May 2022CHF1.2bCHF1.7b-CHF225,735,000.00n/a-5.3x0.7x
Thu, 07 Apr 2022CHF1.3bCHF1.7b-CHF225,735,000.00n/a-5.8x0.8x
Sat, 05 Mar 2022CHF1.4bCHF1.6b-CHF160,341,000.00n/a-8.6x0.9x
Mon, 31 Jan 2022CHF2.2bCHF1.6b-CHF160,341,000.00n/a-13.4x1.3x
Wed, 29 Dec 2021CHF2.4bCHF1.6b-CHF160,341,000.00n/a-14.8x1.5x
Fri, 26 Nov 2021CHF3.2bCHF1.6b-CHF160,341,000.00n/a-20.1x2x
Sun, 24 Oct 2021CHF3.4bCHF1.6b-CHF160,341,000.00n/a-21.5x2.1x
Tue, 21 Sep 2021CHF3.9bCHF1.6b-CHF160,341,000.00n/a-24.1x2.4x
Thu, 19 Aug 2021CHF3.2bCHF1.6b-CHF160,341,000.00n/a-20x2x
Thu, 03 Jun 2021CHF3.2bCHF1.5b-CHF148,018,000.00n/a-21.7x2.1x
Price to Earnings Ratio

-21.7x


Total Market Cap: CHF3.2bTotal Earnings: -CHF148,018,000.00Total Revenue: CHF1.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Drug Retail Industry Price to Earnings3Y Average -7.9x202220232024
Current Industry PE
    There is only one company in the Swiss Drug Retail industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Drug Retail industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 14% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Swiss Drug Retail compare with similar industries?

CH Market-0.38%
Consumer Staples-0.50%
Food and Staples Retail-3.83%
Drug Retail-4.21%
Food Retail2.38%
Food Distributors0%
Big Box Super Stores0%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DOCM DocMorrisCHF81.95-4.2%
CHF16.7m
126.1%PS1.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

DOCM

CHF81.95

DocMorris

7D

-4.2%

1Y

126.1%